type here...

CATEGORIES

Clinical Trials

LATEST

123Page 2 of 3

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

INOVIO’s COVID-19 Vaccine Shows Durable Antibody and T Cell Responses

Medika Life -
INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus

AI is Transforming Health Delivery: A Five-Year Reflection

Gil Bashe, Medika Life Editor -
Beyond Hype AI, ChatGPT and LLMs Are Practical Tools for Improved Care and Optimized Processes

Four Ways COVID has Changed Health Tech

John Whyte MD -
Like most tech lovers, I’m excited about the upcoming CES conference.  I won’t be attending in person but will be watching it very closely...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories